Brain Structural Abnormalities in a Group of Never-Medicated Patients With Long-Term Schizophrenia.

scientific article published on 18 June 2015

Brain Structural Abnormalities in a Group of Never-Medicated Patients With Long-Term Schizophrenia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1176/APPI.AJP.2015.14091108
P698PubMed publication ID26085040
P5875ResearchGate publication ID278791598

P50authorWenjing ZhangQ85398556
P2093author name stringWei Deng
John A Sweeney
Fei Li
Qiyong Gong
Li Yao
Su Lui
Yuan Xiao
Jieke Liu
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectschizophreniaQ41112
P304page(s)995-1003
P577publication date2015-06-18
P1433published inAmerican Journal of PsychiatryQ1935368
P1476titleBrain Structural Abnormalities in a Group of Never-Medicated Patients With Long-Term Schizophrenia
P478volume172

Reverse relations

cites work (P2860)
Q47686000A diffusion weighted imaging study of basal ganglia in schizophrenia.
Q37612065Alterations in Cortical Thickness and White Matter Integrity in Mild-to-Moderate Communicating Hydrocephalic School-Aged Children Measured by Whole-Brain Cortical Thickness Mapping and DTI.
Q48007135An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers
Q64298943Association of a Schizophrenia-Risk Nonsynonymous Variant With Putamen Volume in Adolescents: A Voxelwise and Genome-Wide Association Study
Q47386048Brain Structure Biomarkers in the Psychosis Biotypes: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes
Q94600188Characteristics of gray matter alterations in never-treated and treated chronic schizophrenia patients
Q38872560Combination of volume and perfusion parameters reveals different types of grey matter changes in schizophrenia
Q48460836Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis.
Q53266198Deviation from expected cognitive ability across psychotic disorders.
Q41580027Differential Cortical Gray Matter Deficits in Adolescent- and Adult-Onset First-Episode Treatment-Naïve Patients with Schizophrenia
Q92518217Functional brain networks in never-treated and treated long-term Ill schizophrenia patients
Q41041009Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder
Q90871787Gray matter bases of psychotic features in adult bipolar disorder: A systematic review and voxel-based meta-analysis of neuroimaging studies
Q52091530Is There an Association Between Mismatch Negativity and Cortical Thickness in Schizophrenia Patients?
Q36740180Medial Prefrontal and Anterior Insular Connectivity in Early Schizophrenia and Major Depressive Disorder: A Resting Functional MRI Evaluation of Large-Scale Brain Network Models
Q55341458Multilocus genetic profile in dopaminergic pathway modulates the striatum and working memory.
Q31137558Psychoradiology: The Frontier of Neuroimaging in Psychiatry.
Q59135280Structural and functional brain abnormalities in drug-naive, first-episode, and chronic patients with schizophrenia: a multimodal MRI study
Q38812229Structural neuroimaging across early-stage psychosis: Aberrations in neurobiological trajectories and implications for the staging model.
Q41535826The neurobiology of transition to psychosis: clearing the cache.
Q39002140The treatment of schizophrenia: Can we raise the standard of care?
Q89901286Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning
Q55023835What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?

Search more.